Peptides and Healthy Aging: What to Know
FAQs
Peptides are short amino acid chains that can participate in cellular signaling and other biological processes. Because signaling affects many body systems, peptides are often discussed in connection with repair, metabolism, and communication between cells.
No. Peptides are not one uniform category. Different peptides can have different mechanisms, intended uses, evidence levels, formulations, and safety considerations. That is why broad claims about “peptides” as a whole can be misleading.
No. NAD+ is not a peptide. It is a coenzyme involved in cellular energy metabolism and other cellular processes, so it should not be described as one of the body’s peptides.
Aging is a complex process influenced by many factors, including biology, lifestyle, physical activity, nutrition, sleep, and overall health. For that reason, it is more accurate to view healthy aging as a broad, long-term goal rather than something explained or addressed by any single compound alone.
No. FDA says compounded drugs are not FDA-approved and do not go through the same premarket review for safety, effectiveness, and quality as FDA-approved products. That distinction matters in any discussion about product quality, consistency, and risk.
No. Risk can vary widely depending on the specific compound, formulation, route of administration, and quality of the product. FDA has flagged some compounded peptide-related substances for concerns such as immunogenicity, peptide-related impurities, limited human exposure data, and reported adverse events.
References
-
Federal Trade Commission. Health Products Compliance Guidance. (Federal Trade Commission)
-
U.S. Department of Health and Human Services. Marketing. HIPAA for Professionals. (HHS.gov)
-
Telehealth.HHS.gov. Getting started with licensure. (Telehealth.HHS.gov)
-
U.S. Food and Drug Administration. Understanding the Risks of Compounded Drugs. (U.S. Food and Drug Administration)
-
U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding That May Present Significant Safety Risks. (U.S. Food and Drug Administration)
-
U.S. Food and Drug Administration. VYLEESI (bremelanotide injection) Prescribing Information. (FDA Label PDF)
-
National Institute on Aging. What Do We Know About Healthy Aging? (National Institute on Aging)